In the context of the neuropathy Charcot-Marie-Tooth Type 2A (CMT2A), which is caused by dominant-negative mutations in MFN2, it was suggested that MFN2 behaves as an inhibitor of mitophagy (Rizzo et al., 2016). Here, MFN2 is linked to Charcot-Marie-Tooth disease type 2A1.